An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Efgartigimod Alfa (Vyvgart): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Amifampridine Phosphate (Firdapse): CADTH Reimbursement Recommendation: Indication: For the treatment of Lambert-Eaton myasthenic syndrome in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
Ravulizumab (Ultomiris): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with anti-acetylcholine receptor antibody–positive generalized myasthenia gravis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug.
Practical Approaches to Managing Advanced Kidney Cancer: Version 2020 [Internet].
Rendon R, Kapoor A, authors; Heng DYC, Kollmannsberger C, editors.
Dorval (QC): Canadian Urological Association; 2020.
Intrapartum care.
London: National Institute for Health and Care Excellence (NICE); 2023 Sep 29. (NICE Clinical Guidelines, No. 235.)
Tremelimumab (Imjudo) in Combination With Durvalumab (Imfinzi): CADTH Reimbursement Recommendation: Indication: For the first-line treatment of adult patients with unresectable hepatocellular carcinoma who require systemic therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
WHO guideline for clinical management of exposure to lead [Internet].
Geneva: World Health Organization; 2021.
Ruxolitinib (Jakavi): CADTH Reimbursement Recommendation: Indication: For the treatment of chronic graft-versus-host disease in adults and pediatric patients aged 12 years and older who have inadequate response to corticosteroids or other systemic therapies [Internet].
WHO guidelines for plague management: revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission [Internet].
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Triple-negative breast cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Treatment of Tuberculosis: Guidelines. 4th edition.
Geneva: World Health Organization; 2010.
World Report on Disability 2011.
Geneva: World Health Organization; 2011.
WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents.
Geneva: World Health Organization; 2018.
Clinical Pathways in Stroke Rehabilitation: Evidence-based Clinical Practice Recommendations [Internet].
Platz T, editor.
Cham (CH): Springer; 2021.
CADTH Reimbursement Reviews and Recommendations.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013-.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on